Global Psoriatic Arthritis Epidemiology 10-year Forecasts 2020-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Psoriatic Arthritis – Epidemiology Forecast to 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report delivers an in-depth understanding of the historical and forecasted epidemiology of Psoriatic Arthritis in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

The Psoriatic Arthritis epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool, trends, and assumptions.

Key Findings

The disease epidemiology covered in the report provides historical and forecasted Psoriatic Arthritis epidemiology segmented as the Prevalent cases of Psoriatic Arthritis, Diagnosed cases of Psoriatic Arthritis, Gender-specific cases of Psoriatic Arthritis, Age-specific cases of Psoriatic Arthritis and Severity-specific Prevalence of Psoriatic Arthritis. The report includes the prevalent scenario of Psoriatic Arthritis in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Scope of the Report

• Psoriatic Arthritis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• Psoriatic Arthritis Epidemiology Report and Model provide an overview of the risk factors and global trends of Psoriatic Arthritis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into the historical and forecasted patient pool of Psoriatic Arthritis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Psoriatic Arthritis.
• The report provides the segmentation of the Psoriatic Arthritis epidemiology by total prevalent cases of Psoriatic Arthritis in the 7MM.
• The report provides the segmentation of the Psoriatic Arthritis epidemiology by diagnosed cases of Psoriatic Arthritis in the 7MM.
• The report provides the segmentation of the Psoriatic Arthritis epidemiology by gender-specific cases of Psoriatic Arthritis in the 7MM.
• The report provides the segmentation of the Psoriatic Arthritis epidemiology by age-specific cases of Psoriatic Arthritis in the 7MM.
• The report provides the segmentation of the Psoriatic Arthritis epidemiology by the severity-specific prevalence of Psoriatic Arthritis in the 7MM.

Report Highlights

• 10-year Forecast of Psoriatic Arthritis epidemiology
• 7MM Coverage
• Prevalent cases of Psoriatic Arthritis
• Diagnosed Prevalent Cases of Psoriatic Arthritis
• Gender-specific Cases of Psoriatic Arthritis
• Age-specific Cases of Psoriatic Arthritis
• Severity-specific Prevalence of Psoriatic Arthritis

   

Key Questions Answered

• What will be the growth opportunities in the 7MM for the patient population pertaining to Psoriatic Arthritis?
• What are the key findings pertaining to the Psoriatic Arthritis epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2018-2030)?
• What would be the total number of patients with Psoriatic Arthritis across the 7MM during the forecast period (2018-2030)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2018-2030)?
• At what CAGR the patient population is expected to grow by in the 7MM during the forecast period (2018-2030)?
• What are the disease risk, burdens, and unmet needs of Psoriatic Arthritis?
• What are the currently available treatments for Psoriatic Arthritis?

   

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/jaeh5b

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900